1. Home
  2. MOGO vs ANEB Comparison

MOGO vs ANEB Comparison

Compare MOGO & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mogo Inc.

MOGO

Mogo Inc.

HOLD

Current Price

$1.06

Market Cap

27.6M

Sector

N/A

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$1.08

Market Cap

96.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGO
ANEB
Founded
2003
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6M
96.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MOGO
ANEB
Price
$1.06
$1.08
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$4.00
N/A
AVG Volume (30 Days)
107.3K
102.1K
Earning Date
11-07-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$29,215,516.00
N/A
Revenue This Year
$63.05
N/A
Revenue Next Year
$5.58
N/A
P/E Ratio
$4.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.90
52 Week High
$3.83
$3.42

Technical Indicators

Market Signals
Indicator
MOGO
ANEB
Relative Strength Index (RSI) 32.09 18.73
Support Level $1.09 $1.14
Resistance Level $1.15 $2.40
Average True Range (ATR) 0.05 0.19
MACD 0.01 -0.12
Stochastic Oscillator 12.50 4.23

Price Performance

Historical Comparison
MOGO
ANEB

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: